When will Everolimus Tablet be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Everolimus Tablet changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Everolimus Tablet

Brand names: Everolimus

Category: Transplant

Not specified 11

FDA status: To Be Discontinued · Last FDA update: Nov 3, 2025 · First posted: Jan 6, 2026 · 3 manufacturers, 11 listed presentations

As of Nov 3, 2025, the FDA lists Everolimus Tablet as being discontinued. Of 11 manufacturer presentations, 11 Not specified.

Ask your pharmacist: which of the 3 manufacturers below can they order right now, and whether a different strength or form of Everolimus Tablet is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Everolimus, Tablet, 2 mg (NDC 0378-0005-85) NDC 0378-0005-85	Mylan Pharmaceuticals Inc., a Viatris Company	Not specified	Discontinuation of the manufacture of the drug
Everolimus, Tablet, 2.5 mg (NDC 49884-119-91) NDC 49884-119-91	Endo Pharmaceuticals, Inc.	Not specified	Discontinuation of the manufacture of the drug
Everolimus, Tablet, 2.5 mg (NDC 0093-7766-24) NDC 0093-7766-24	Teva Pharmaceuticals USA, Inc.	Not specified	Discontinuation of the manufacture of the drug
Everolimus, Tablet, 3 mg (NDC 0378-0006-85) NDC 0378-0006-85	Mylan Pharmaceuticals Inc., a Viatris Company	Not specified	Discontinuation of the manufacture of the drug
Everolimus, Tablet, 5 mg (NDC 49884-125-91) NDC 49884-125-91	Endo Pharmaceuticals, Inc.	Not specified	Discontinuation of the manufacture of the drug
Everolimus, Tablet, 5 mg (NDC 0378-0007-85) NDC 0378-0007-85	Mylan Pharmaceuticals Inc., a Viatris Company	Not specified	Discontinuation of the manufacture of the drug
Everolimus, Tablet, 5 mg (NDC 0093-7767-24) NDC 0093-7767-24	Teva Pharmaceuticals USA, Inc.	Not specified	Discontinuation of the manufacture of the drug
Everolimus, Tablet, 7.5 mg (NDC 49884-127-91) NDC 49884-127-91	Endo Pharmaceuticals, Inc.	Not specified	Discontinuation of the manufacture of the drug
Everolimus, Tablet, 7.5 mg (NDC 0093-7768-24) NDC 0093-7768-24	Teva Pharmaceuticals USA, Inc.	Not specified	Discontinuation of the manufacture of the drug
Everolimus, Tablet, 10 mg (NDC 49884-128-91) NDC 49884-128-91	Endo Pharmaceuticals, Inc.	Not specified	Discontinuation of the manufacture of the drug
Everolimus, Tablet, 10 mg (NDC 0093-7769-24) NDC 0093-7769-24	Teva Pharmaceuticals USA, Inc.	Not specified	Discontinuation of the manufacture of the drug

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Everolimus Tablet (FDA data as of Nov 3, 2025). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Everolimus Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Everolimus Tablet.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/everolimus-tablet.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).